drugset / Trial / NCT02453932

Efficacy and Safety of Tianzhi Granule in Mild to Moderate Vascular Dementia

NCT02453932

Phase 3 Completed 543 enrolled Dongzhimen Hospital, Beijing
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This ongoing study aimed to evaluate the efficacy and safety of Tianzhi granule in mild to moderate vascular dementia in a more reasonable design.

Timeline

Start
2013-10
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Donepezil Small molecule 5 mg
Subject Tianzhi granule Unknown 5 g

Indications